Latest News about COVID/19 vaccine
Recent news which mentions COVID/19 vaccine
From Benzinga
 
   Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies
   
  April 21, 2022
  Tickers 
   CDAK
  
  
  From Benzinga
 
   Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab
   
  April 19, 2022
  Tickers 
   MRNA
  
  
  From Benzinga
 From Benzinga
 
   Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
   
  
  
  April 18, 2022
  From Benzinga
 From Benzinga
 
   As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
   
  
  
  April 18, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Pfizer/BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Aged 5-11 Years
   
  
  
  April 14, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Vaxxinity Receives $9.25M Funding From CEPI To Support Pivotal COVID-19 Vaccine Trial
   
  April 07, 2022
  Tickers 
   VAXX
  
  
  From Benzinga
 
   Talaris Therapeutics Reveals COVID-19 Outcomes Among Kidney Transplant Patients Treated With FCR001
   
  April 07, 2022
  Tickers 
   TALS
  
  
  From Benzinga
 From Benzinga
 
   Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study Shows
   
  
  
  April 06, 2022
  From Benzinga
 
   mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT
   
  
  
  April 05, 2022
  From Benzinga
 
   CDC Says Heart Inflammation Risk Higher After COVID-19 Infection Than mRNA Vaccines: CNBC
   
  
  
  April 04, 2022
  From Benzinga
 
   Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC
   
  
  
  April 01, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

